Skip to main content
. Author manuscript; available in PMC: 2012 Feb 9.
Published in final edited form as: Brain Res. 2008 Aug 29;1238:143–153. doi: 10.1016/j.brainres.2008.08.053

Fig 3. Neurological deficits in mice subjected to GM6 treatment.

Fig 3

All mice were subjected to 1 hour of cerebral ischemia followed by 24 hours of reperfusion. Animals were injected with vehicle (control) or GM6 at 1 mg/kg or 5 mg/kg intravenously at the end of the ischemic period. Neurological deficits were measured at the end of reperfusion (22 hrs) as outlined in the Experimental Methods. *p <0.04 for GM6 (1mg/kg) compared to control; **p < 0.0006 for GM6 (5mg/kg) compared to control.